Study on the pharmacokinetics and bioequivalence of domestic amlodipine besylate tablets in healthy volunteers
LI Fei-er
Abstract
LI Fei-er
Abstract
OBJECTIVE To study the pharmacokinetics profiles and bioequivalence of domestic and imported amlodipine besylate tables in healthy volunteers.METHODS A single oral dose of 10 mg domestic or imported amlodipine besylate tables were given to 20 healthy male volunteers in an open randomized crossover design.Concentrations of amlodipine in plasma were determined by LC-MS.The pharmacokinetic parameters and relative bioavailability were calculated by DAS 2.0 program to evaluate the bioequivalence of the two preparations.RESULTS The main pharmacokinetic parameters of the two preparations were as follows: AUC0-120 were(306.1±60.7)μg·h·L-1 and(315.1±62.7)μg·h·L-1,AUC0∞ were(330.3±59.8)μg·h·L-1 and(341.7±67.2) μg·h·L-1;Cmax were(7.6±1.7 ) μg·L-1 and(7.8±1.6) μg·L-1;tmax were(7.7±2.2) h and(7.4±2.1) h;t1/2 were(35.4±6.3) h and(36.4±5.1) h respectively.The relative bioavailability of domestic to imported tablets were 98.3%±13.2%(F0-120) and 98.0%±12.5%(F0-∞).CONCLUSION The results of the statistical analysis show that the two preparations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To study the pharmacokinetics profiles and bioequivalence of domestic and imported amlodipine besylate tables in healthy volunteers.METHODS A single oral dose of 10 mg domestic or imported amlodipine besylate tables were given to 20 healthy male volunteers in an open randomized crossover design.Concentrations of amlodipine in plasma were determined by LC-MS.The pharmacokinetic parameters and relative bioavailability were calculated by DAS 2.0 program to evaluate the bioequivalence of the two preparations.RESULTS The main pharmacokinetic parameters of the two preparations were as follows: AUC0-120 were(306.1±60.7)μg·h·L-1 and(315.1±62.7)μg·h·L-1,AUC0∞ were(330.3±59.8)μg·h·L-1 and(341.7±67.2) μg·h·L-1;Cmax were(7.6±1.7 ) μg·L-1 and(7.8±1.6) μg·L-1;tmax were(7.7±2.2) h and(7.4±2.1) h;t1/2 were(35.4±6.3) h and(36.4±5.1) h respectively.The relative bioavailability of domestic to imported tablets were 98.3%±13.2%(F0-120) and 98.0%±12.5%(F0-∞).CONCLUSION The results of the statistical analysis show that the two preparations are bioequivalent.
Key concepts: Bioequivalence, Pharmacokinetics, Amlodipine, Bioavailability, Cmax, Pharmacology, Crossover study, Medicine